International Journal for Research in Applied Science and Engineering Technology · Mar 25, 2026

Early Detection of Alzheimer’s Disease Using Voice Biomarkers and Deep Learning

By Nandre PS

Alzheimer’s disease is a progressive neurodegenerative disorder and the most common cause of dementia worldwide. Early detection plays a vital role in improving treatment effectiveness, patient care planning, and slowing cognitive decline. This research presents an application-based deep learning system designed to detect early-stage Alzheimer’s disease through analysis of voice biomarkers. The solution leverages patient voice recordings to capture linguistic and acoustic markers such as pause duration, speech rate, articulation clarity, pitch variation, amplitude dynamics, and lexical diversity. These features are extracted via automated signal processing pipelines, with categorical inputs (e.g. demographic data) encoded and missing acoustic values imputed using statistically robust methods to maintain dataset consistency. The deep learning architecture combines Convolutional Neural Networks (CNNs) for high resolution spectrogram feature extraction with Long Short-Term Memory (LSTM) networks for temporal sequence modelling, enabling detection of subtle, time-dependent speech pattern changes associated with cognitive decline. The model is rigorously trained, while performance is assessed through accuracy, Area Under the Curve (AUC), F1 score, precision, and recall to ensure reliability and clinical relevance. Unlike web-based deployments, this system is delivered as a standalone, cross-platform desktop application, capable of running locally without internet connectivity. The application includes an intuitive interface for healthcare providers, caregivers, and researchers to record or upload voice samples and receive real-time Alzheimer’s risk assessments directly on their devices.

doi.org/10.22214/ijraset.2026.78636Open accessBiomarkers

AgingResearch.News